# Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients

> **NCT00449410** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 35 (—)

## Conditions studied

- Atrial Fibrillation
- Neuropsychology
- Magnetic Resonance Imaging
- Inflammation
- Hemostasis

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** ezetimibe

## Key facts

- **NCT ID:** NCT00449410
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 35 (—)
- **Last updated:** 2007-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449410, "Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT00449410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*